Samir Khleif, Georgiamune CEO
October 22, 2026 07:30 AM EDT
Exclusive: Georgiamune sells solid tumor drug to Italy's Menarini for up to $1.1B
A small Maryland biotech is shipping a preclinical cancer drug to a family-owned Italian pharma in a deal worth up to $1.1 billion if all …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Think we're worth reading - tell Google.
Confirm Endpoints as a trusted biopharma news source
ENDPOINTS CAREERS